NovaBridge Biosciences (NBP) Amortizatization of Intangibles (2020)

NovaBridge Biosciences (NBP) reported Amortizatization of Intangibles of -$811655.0 for Q4 2020, down 295.61% quarter-over-quarter from $414943.7 in Q3 2020.

NovaBridge Biosciences (NBP) Amortizatization of Intangibles (2020) Analysis & Trends

NovaBridge Biosciences (NBP) has 1 years of Amortizatization of Intangibles data on file, last reported at -$811655.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - 13,267.00
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn -
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn -
9 Abivax 93.46 Bn 93.46 Bn - -
10 NovaBridge Biosciences 331.49 Mn 120.65 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -811,655.04
Dec 31, 2020 -811,655.04
Sep 30, 2020 414,943.75
Sep 30, 2020 414,943.75